Author: masuuglobal
What Is Global Regulatory Strategy?
What Is Global Regulatory Strategy? Global regulatory strategy is a methodical approach that is created by pharmaceutical firms in order to acquire and sustain regulatory acceptance of their products in various nations.
What Is Pharmaceutical Regulatory Compliance?
What Is Pharmaceutical Regulatory Compliance? Pharmaceutical regulatory compliance is the procedure through which pharmaceutical companies adhere to the set regulations, guidelines, and industry standards in order to guarantee the safety, quality, and efficacy of medicines.
Mastering EU eCTD Submissions: Strategies for Compliance and Success
Mastering EU eCTD Submissions: Strategies for Compliance and Success EU eCTD Submissions have become increasingly complex as regulatory standards continue to evolve across Europe. The filing of regulatory dossiers is no longer straightforward, with changing expectations from the European Medicines Agency and other health authorities.
What is UDI (Unique Device Identification)?
What is UDI (Unique Device Identification)? In the modern healthcare system, ensuring the safety and traceability of medical devices is extremely important. Unique Device Identification (UDI) is a global regulatory system designed to assign a unique code to every medical device. This system helps manufacturers, regulators, and healthcare providers easily identify and track devices throughout… Continue reading What is UDI (Unique Device Identification)?
EU eCTD Submissions 2026: Key Updates from EMA
EU eCTD Submissions 2026: Key Updates from EMA European regulatory environment is still kept changing, and the European Medicines Agency (EMA) has been proposing essential changes to the EU eCTD submissions. In the case of pharmaceutical and life sciences firms that focus on Europe, compliance is no longer a choice to make but a necessity… Continue reading EU eCTD Submissions 2026: Key Updates from EMA
eCTD Guidance for Marketing Authorisation and Post-Authorisation Applications in Europe: A 2026 Regulatory Perspective
eCTD Guidance for Marketing Authorisation and Post-Authorisation Applications in Europe: A 2026 Regulatory Perspective Most of the regulatory processes in Europe are required to submit Electronic Common Technical Document (eCTD). Standardized electronic dossiers are required by the European Medicines Agency (EMA) and national competent authorities of the Marketing Authorisation Application (MAA) and the Post-Authorisation Application… Continue reading eCTD Guidance for Marketing Authorisation and Post-Authorisation Applications in Europe: A 2026 Regulatory Perspective
What is a Periodic Safety Update Report (PSUR)
What is a Periodic Safety Update Report (PSUR)? In the pharmaceutical industry, monitoring the safety of medicines does not stop after a drug is approved and marketed. Continuous safety evaluation is essential to identify potential risks and ensure patient protection. A Periodic Safety Update Report (PSUR) is a key pharmacovigilance document that provides updated safety… Continue reading What is a Periodic Safety Update Report (PSUR)
What are Good Practice (GxP) Guidelines and Regulations?
What are Good Practice (GxP) Guidelines and Regulations? In the pharmaceutical and life sciences industries, maintaining product quality, safety, and regulatory compliance is essential. Good Practice (GxP) guidelines are a set of quality regulations that ensure drugs, medical devices, and healthcare products are consistently produced, tested, and monitored according to strict standards.
What Is eCTD Submission? A Complete Guide for Pharmaceutical Companies
What Is eCTD Submission? A Complete Guide for Pharmaceutical Companies With the pharmaceutical industry being highly regulated today, the regulatory submissions must be precise, organized, and in line with international standards. The Electronic Common Technical Document (eCTD) is one of the most popular forms of regulatory submissions.
What Is eCTD Software? A Complete Guide for Regulatory Submissions
What Is eCTD Software Regulatory submissions in the pharmaceutical and life sciences industry should be done under stringent world standards. The regulatory bodies in most countries of the world demand that the companies provide huge amounts of paperwork in regard to the development of drugs, clinical trials, and quality of the products.